Acomplia is an oral prescription medication which has created waves in the weight loss market ever since its launch in the UK. Subsequent to which it has been launched in various other countries such as France, Germany, Ireland, Austria, Argentina, Denmark, Holland and Sweden. Some of the prospective countries which can witness the launch of this weight loss medication include Italy, Spain, and Mexico. Use of Acomplia may cause a few adverse effects as a consequence of bodily changes in response to this medication. Yet, regardless of the adverse effects it sources such as anxiety and feeling of depression, Acomplia is still preferred by obese and overweight individuals who desire to lose weight. “Prescription medication attaches the pre-requisite to procure a medical advice, but Alli can ease you of the hassle to run around doctor’s clinics. This is one reason why dieters round the globe are eagerly awaiting its launch which is likely to be around the month of July”. Alli diet pill is presently under its pre-launch test. Glaxo-SmithKline, the drug-maker intends to provide 3-month supply to about 400 dieters prior to its launch in the stores. This weight loss medication works by obstructing the fat absorption into the body. Consumption of this diet drug thereby is effective in giving ample opportunity to the already stored in fat to generate the required energy, assisting in trimming down of excessive fat. This is in turn consequential in effective weight loss. For more visit http://acomplia.smyr.se